Scorpion Venom Proteomics: Mining for Cancer Drug Candidates

Comprehensive proteomic analysis of scorpion venom identifies cancer-fighting peptide candidates through systematic characterization of venom peptide diversity.

Arcos, Stephanie Santos Suehiro et al.·International journal of molecular sciences·2025·Preliminary EvidenceReview
RPEP-09970ReviewPreliminary Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Preliminary Evidence
Sample
N=N/A
Participants
Preclinical research on scorpion venom-derived anticancer peptides

What This Study Found

Comprehensive proteomic analysis of scorpion venom identifies cancer-fighting peptide candidates through systematic characterization of venom peptide diversity.

Key Numbers

Review covers multiple scorpion species and venom components including neurotoxins, antimicrobial peptides, and enzymes.

How They Did This

In publication.

Why This Research Matters

Relevant to peptide therapeutics.

The Bigger Picture

Advances peptide evidence.

What This Study Doesn't Tell Us

In publication.

Questions This Raises

  • ?Long-term implications?
  • ?Evidence comparison?
  • ?Next steps?

Trust & Context

Key Stat:
Key finding Comprehensive proteomic analysis of scorpion venom identifies cancer-fighting peptide candidates thr
Evidence Grade:
Based on design.
Study Age:
Published in 2025.
Original Title:
Scorpion Venom as a Source of Cancer Drugs: A Comprehensive Proteomic Analysis and Therapeutic Potential.
Published In:
International journal of molecular sciences, 26(20) (2025)
Database ID:
RPEP-09970

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What does this mean?

Comprehensive proteomic analysis of scorpion venom identifies cancer-fighting peptide candidates through systematic characterization of venom peptide diversity.

How reliable?

Consult publication.

Read More on RethinkPeptides

Cite This Study

RPEP-09970·https://rethinkpeptides.com/research/RPEP-09970

APA

Arcos, Stephanie Santos Suehiro; Aguiar, Mariana Ramos da Cunha; Oliveira, Júlia de; Silva, Matheus Ramos da; Pimentel, Isabela de Oliveira Cavalcante; Dos Anjos, Nicolas Gamboa; Machado, Gustavo Henrique Rohr Souza; Evangelista, Kimberly Borges; Portaro, Fernanda Calheta Vieira; Iwai, Leo Kei. (2025). Scorpion Venom as a Source of Cancer Drugs: A Comprehensive Proteomic Analysis and Therapeutic Potential.. International journal of molecular sciences, 26(20). https://doi.org/10.3390/ijms26209907

MLA

Arcos, Stephanie Santos Suehiro, et al. "Scorpion Venom as a Source of Cancer Drugs: A Comprehensive Proteomic Analysis and Therapeutic Potential.." International journal of molecular sciences, 2025. https://doi.org/10.3390/ijms26209907

RethinkPeptides

RethinkPeptides Research Database. "Scorpion Venom as a Source of Cancer Drugs: A Comprehensive ..." RPEP-09970. Retrieved from https://rethinkpeptides.com/research/arcos-2025-scorpion-venom-as-a

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.